Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics – GlobeNewswire

Orchestra BioMed to Receive Up to $21 Million in Proceeds from buyout of Vivasure by Haemonetics  GlobeNewswire

Source: news.google.com

Leave a Comment

Your email address will not be published. Required fields are marked *